APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antithrombin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antithrombin Market Analysis and Forecast 2026-2032

Report ID 173966640221 December 2025190 pages

Choose your research edition.

Industry ResearchAntithrombin Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithrombin Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Antithrombin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithrombin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithrombin Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Antithrombin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antithrombin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antithrombin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antithrombin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antithrombin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antithrombin include Takeda, Scripps Laboratories Inc., Grifols, rEVO Biologics Inc., Lee Biosolutions, Kedrion S.p.A. and CSL Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antithrombin, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antithrombin, also provides the revenue of main regions and countries. Of the upcoming market potential for Antithrombin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antithrombin revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antithrombin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antithrombin revenue, projected growth trends, production technology, application and end-user industry.

Antithrombin Segment by Company

Takeda

Scripps Laboratories Inc.

Grifols

rEVO Biologics Inc.

Lee Biosolutions

Kedrion S.p.A.

CSL Limited

Antithrombin Segment by Type

Liquid

Lyophilized

Antithrombin Segment by Application

Diagnostics

Research

Therapeutics

Antithrombin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithrombin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithrombin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithrombin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antithrombin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antithrombin company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antithrombin revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antithrombin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquid Major Player Table 3. Lyophilized Major Player Table 4. Global Antithrombin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diagnostics Major Player Table 6. Research Major Player Table 7. Therapeutics Major Player Table 8. Antithrombin Industry Trends Table 9. Antithrombin Industry Drivers Table 10. Antithrombin Industry Opportunities and Challenges Table 11. Antithrombin Industry Restraints Table 12. Global Antithrombin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Antithrombin Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Antithrombin Market Share by Region (2021-2026) Table 15. Global Antithrombin Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Antithrombin Market Share by Region (2027-2032) Table 17. Global Antithrombin Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Antithrombin Revenue Market Share by Players (2021-2026) Table 19. Global Antithrombin Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Antithrombin Key Players Headquarters & Area Served Table 21. Global Antithrombin Players, Product Type & Application Table 22. Global Antithrombin Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Antithrombin by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Antithrombin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antithrombin Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Antithrombin Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Antithrombin Revenue Market Share by Type (2021-2026) Table 29. Global Antithrombin Revenue Market Share by Type (2027-2032) Table 30. Global Antithrombin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antithrombin Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Antithrombin Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Antithrombin Revenue Market Share by Application (2021-2026) Table 34. Global Antithrombin Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Antithrombin Product Portfolio Table 39. Takeda Recent Development Table 40. Scripps Laboratories Inc. Company Information Table 41. Scripps Laboratories Inc. Business Overview Table 42. Scripps Laboratories Inc. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Scripps Laboratories Inc. Antithrombin Product Portfolio Table 44. Scripps Laboratories Inc. Recent Development Table 45. Grifols Company Information Table 46. Grifols Business Overview Table 47. Grifols Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Grifols Antithrombin Product Portfolio Table 49. Grifols Recent Development Table 50. rEVO Biologics Inc. Company Information Table 51. rEVO Biologics Inc. Business Overview Table 52. rEVO Biologics Inc. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. rEVO Biologics Inc. Antithrombin Product Portfolio Table 54. rEVO Biologics Inc. Recent Development Table 55. Lee Biosolutions Company Information Table 56. Lee Biosolutions Business Overview Table 57. Lee Biosolutions Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Lee Biosolutions Antithrombin Product Portfolio Table 59. Lee Biosolutions Recent Development Table 60. Kedrion S.p.A. Company Information Table 61. Kedrion S.p.A. Business Overview Table 62. Kedrion S.p.A. Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Kedrion S.p.A. Antithrombin Product Portfolio Table 64. Kedrion S.p.A. Recent Development Table 65. CSL Limited Company Information Table 66. CSL Limited Business Overview Table 67. CSL Limited Antithrombin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. CSL Limited Antithrombin Product Portfolio Table 69. CSL Limited Recent Development Table 70. North America Antithrombin Revenue by Type (2021-2026) & (US$ Million) Table 71. North America Antithrombin Revenue by Type (2027-2032) & (US$ Million) Table 72. North America Antithrombin Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Antithrombin Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Antithrombin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Antithrombin Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Antithrombin Revenue by Country (US$ Million) & (2027-2032) Table 77. Europe Antithrombin Revenue by Type (2021-2026) & (US$ Million) Table 78. Europe Antithrombin Revenue by Type (2027-2032) & (US$ Million) Table 79. Europe Antithrombin Revenue by Application (2021-2026) & (US$ Million) Table 80. Europe Antithrombin Revenue by Application (2027-2032) & (US$ Million) Table 81. Europe Antithrombin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Antithrombin Revenue by Country (2021-2026) & (US$ Million) Table 83. Europe Antithrombin Revenue by Country (US$ Million) & (2027-2032) Table 84. China Antithrombin Revenue by Type (2021-2026) & (US$ Million) Table 85. China Antithrombin Revenue by Type (2027-2032) & (US$ Million) Table 86. China Antithrombin Revenue by Application (2021-2026) & (US$ Million) Table 87. China Antithrombin Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia Antithrombin Revenue by Type (2021-2026) & (US$ Million) Table 89. Asia Antithrombin Revenue by Type (2027-2032) & (US$ Million) Table 90. Asia Antithrombin Revenue by Application (2021-2026) & (US$ Million) Table 91. Asia Antithrombin Revenue by Application (2027-2032) & (US$ Million) Table 92. Asia Antithrombin Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Antithrombin Revenue by Region (US$ Million) & (2021-2026) Table 94. Asia Antithrombin Revenue by Region (US$ Million) & (2027-2032) Table 95. SAMEA Antithrombin Revenue by Type (2021-2026) & (US$ Million) Table 96. SAMEA Antithrombin Revenue by Type (2027-2032) & (US$ Million) Table 97. SAMEA Antithrombin Revenue by Application (2021-2026) & (US$ Million) Table 98. SAMEA Antithrombin Revenue by Application (2027-2032) & (US$ Million) Table 99. SAMEA Antithrombin Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. SAMEA Antithrombin Revenue by Country (2021-2026) & (US$ Million) Table 101. SAMEA Antithrombin Revenue by Country (US$ Million) & (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Antithrombin Image Figure 2. Global Antithrombin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithrombin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquid Image Figure 5. Lyophilized Image Figure 6. Global Antithrombin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antithrombin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diagnostics Image Figure 9. Research Image Figure 10. Therapeutics Image Figure 11. Global Antithrombin Market Size (US$ Million) & (2021-2032) Figure 12. Global Antithrombin Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antithrombin Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Antithrombin Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Antithrombin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antithrombin Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Antithrombin Revenue Market Share by Type (2021-2032) Figure 19. Global Antithrombin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antithrombin Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Antithrombin Revenue Market Share by Application (2021-2032) Figure 22. North America Antithrombin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Antithrombin Revenue Share by Type (2021-2032) Figure 24. North America Antithrombin Revenue Share by Application (2021-2032) Figure 25. North America Antithrombin Revenue Share by Country (2021-2032) Figure 26. United States Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Antithrombin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Antithrombin Revenue Share by Type (2021-2032) Figure 31. Europe Antithrombin Revenue Share by Application (2021-2032) Figure 32. Europe Antithrombin Revenue Share by Country (2021-2032) Figure 33. Germany Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Antithrombin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Antithrombin Revenue Share by Type (2021-2032) Figure 43. China Antithrombin Revenue Share by Application (2021-2032) Figure 44. Asia Antithrombin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Antithrombin Revenue Share by Type (2021-2032) Figure 46. Asia Antithrombin Revenue Share by Application (2021-2032) Figure 47. Asia Antithrombin Revenue Share by Region (2021-2032) Figure 48. Japan Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Antithrombin Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Antithrombin Revenue Share by Type (2021-2032) Figure 56. SAMEA Antithrombin Revenue Share by Application (2021-2032) Figure 57. SAMEA Antithrombin Revenue Share by Country (2021-2032) Figure 58. Brazil Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Antithrombin Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Lyophilized
Applications
  • Diagnostics
  • Research
  • Therapeutics
Companies covered
  • Takeda
  • Scripps Laboratories Inc.
  • Grifols
  • rEVO Biologics Inc.
  • Lee Biosolutions
  • Kedrion S.p.A.
  • CSL Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antithrombin Market by Type
  3. 1.2.1 Global Antithrombin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid
  5. 1.2.3 Lyophilized
  6. 1.3 Antithrombin Market by Application
  7. 1.3.1 Global Antithrombin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnostics
  9. 1.3.3 Research
  10. 1.3.4 Therapeutics
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Antithrombin Market Dynamics
  1. 2.1 Antithrombin Industry Trends
  2. 2.2 Antithrombin Industry Drivers
  3. 2.3 Antithrombin Industry Opportunities and Challenges
  4. 2.4 Antithrombin Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antithrombin Market Perspective (2021-2032)
  2. 3.2 Global Antithrombin Growth Trends by Region
  3. 3.2.1 Global Antithrombin Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antithrombin Market Size by Region (2021-2026)
  5. 3.2.3 Global Antithrombin Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antithrombin Revenue by Players
  2. 4.1.1 Global Antithrombin Revenue by Players (2021-2026)
  3. 4.1.2 Global Antithrombin Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antithrombin Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antithrombin Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antithrombin Key Players Headquarters & Area Served
  7. 4.4 Global Antithrombin Players, Product Type & Application
  8. 4.5 Global Antithrombin Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antithrombin Market CR5 and HHI
  11. 4.6.3 2025 Antithrombin Tier 1, Tier 2, and Tier 3
5 Antithrombin Market Size by Type
  1. 5.1 Global Antithrombin Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antithrombin Revenue by Type (2021-2032)
  3. 5.3 Global Antithrombin Revenue Market Share by Type (2021-2032)
6 Antithrombin Market Size by Application
  1. 6.1 Global Antithrombin Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antithrombin Revenue by Application (2021-2032)
  3. 6.3 Global Antithrombin Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Antithrombin Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Antithrombin Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Scripps Laboratories Inc.
  8. 7.2.1 Scripps Laboratories Inc. Company Information
  9. 7.2.2 Scripps Laboratories Inc. Business Overview
  10. 7.2.3 Scripps Laboratories Inc. Antithrombin Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Scripps Laboratories Inc. Antithrombin Product Portfolio
  12. 7.2.5 Scripps Laboratories Inc. Recent Developments
  13. 7.3 Grifols
  14. 7.3.1 Grifols Company Information
  15. 7.3.2 Grifols Business Overview
  16. 7.3.3 Grifols Antithrombin Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Grifols Antithrombin Product Portfolio
  18. 7.3.5 Grifols Recent Developments
  19. 7.4 rEVO Biologics Inc.
  20. 7.4.1 rEVO Biologics Inc. Company Information
  21. 7.4.2 rEVO Biologics Inc. Business Overview
  22. 7.4.3 rEVO Biologics Inc. Antithrombin Revenue and Gross Margin (2021-2026)
  23. 7.4.4 rEVO Biologics Inc. Antithrombin Product Portfolio
  24. 7.4.5 rEVO Biologics Inc. Recent Developments
  25. 7.5 Lee Biosolutions
  26. 7.5.1 Lee Biosolutions Company Information
  27. 7.5.2 Lee Biosolutions Business Overview
  28. 7.5.3 Lee Biosolutions Antithrombin Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Lee Biosolutions Antithrombin Product Portfolio
  30. 7.5.5 Lee Biosolutions Recent Developments
  31. 7.6 Kedrion S.p.A.
  32. 7.6.1 Kedrion S.p.A. Company Information
  33. 7.6.2 Kedrion S.p.A. Business Overview
  34. 7.6.3 Kedrion S.p.A. Antithrombin Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Kedrion S.p.A. Antithrombin Product Portfolio
  36. 7.6.5 Kedrion S.p.A. Recent Developments
  37. 7.7 CSL Limited
  38. 7.7.1 CSL Limited Company Information
  39. 7.7.2 CSL Limited Business Overview
  40. 7.7.3 CSL Limited Antithrombin Revenue and Gross Margin (2021-2026)
  41. 7.7.4 CSL Limited Antithrombin Product Portfolio
  42. 7.7.5 CSL Limited Recent Developments
8 North America
  1. 8.1 North America Antithrombin Revenue (2021-2032)
  2. 8.2 North America Antithrombin Revenue by Type (2021-2032)
  3. 8.2.1 North America Antithrombin Revenue by Type (2021-2026)
  4. 8.2.2 North America Antithrombin Revenue by Type (2027-2032)
  5. 8.3 North America Antithrombin Revenue Share by Type (2021-2032)
  6. 8.4 North America Antithrombin Revenue by Application (2021-2032)
  7. 8.4.1 North America Antithrombin Revenue by Application (2021-2026)
  8. 8.4.2 North America Antithrombin Revenue by Application (2027-2032)
  9. 8.5 North America Antithrombin Revenue Share by Application (2021-2032)
  10. 8.6 North America Antithrombin Revenue by Country
  11. 8.6.1 North America Antithrombin Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antithrombin Revenue by Country (2021-2026)
  13. 8.6.3 North America Antithrombin Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antithrombin Revenue (2021-2032)
  2. 9.2 Europe Antithrombin Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antithrombin Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antithrombin Revenue by Type (2027-2032)
  5. 9.3 Europe Antithrombin Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antithrombin Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antithrombin Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antithrombin Revenue by Application (2027-2032)
  9. 9.5 Europe Antithrombin Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antithrombin Revenue by Country
  11. 9.6.1 Europe Antithrombin Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antithrombin Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antithrombin Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antithrombin Revenue (2021-2032)
  2. 10.2 China Antithrombin Revenue by Type (2021-2032)
  3. 10.2.1 China Antithrombin Revenue by Type (2021-2026)
  4. 10.2.2 China Antithrombin Revenue by Type (2027-2032)
  5. 10.3 China Antithrombin Revenue Share by Type (2021-2032)
  6. 10.4 China Antithrombin Revenue by Application (2021-2032)
  7. 10.4.1 China Antithrombin Revenue by Application (2021-2026)
  8. 10.4.2 China Antithrombin Revenue by Application (2027-2032)
  9. 10.5 China Antithrombin Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antithrombin Revenue (2021-2032)
  2. 11.2 Asia Antithrombin Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antithrombin Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antithrombin Revenue by Type (2027-2032)
  5. 11.3 Asia Antithrombin Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antithrombin Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antithrombin Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antithrombin Revenue by Application (2027-2032)
  9. 11.5 Asia Antithrombin Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antithrombin Revenue by Country
  11. 11.6.1 Asia Antithrombin Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antithrombin Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antithrombin Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antithrombin Revenue (2021-2032)
  2. 12.2 SAMEA Antithrombin Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antithrombin Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antithrombin Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antithrombin Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antithrombin Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antithrombin Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antithrombin Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antithrombin Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antithrombin Revenue by Country
  11. 12.6.1 SAMEA Antithrombin Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antithrombin Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antithrombin Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst